会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明专利
    • Novel 1-substituted imidazole nucleoside and its preparation
    • 新一代取代的咪唑烷核苷及其制备
    • JPS5931797A
    • 1984-02-20
    • JP14316282
    • 1982-08-18
    • Sumitomo Chem Co Ltd
    • TARUMI YUUZOUATAMI TOSHIOYOSHIDA NOBORU
    • C07H19/052A61K31/70A61K31/7042A61K31/7052A61K31/7056A61P17/16A61P37/06C07H19/04
    • NEW MATERIAL:The compound of formula I (R is β-D-glucopyranosyl, β-D- galactopyranosyl, 2-acetamido-2-deoxy-β-D-glucopyranosyl, α-L-rhamnopyranosyl, β-D-ribopyranosyl, β-D-arabinofuranosyl, etc.).
      EXAMPLE: 4- Carbamoyl-1-( 2,3,4,6- tetra-O- acetyl-β-D- galactopyranosyl)-imidazolium- 5-olate (I:R=2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl).
      USE: Immunosuppressive agent and antitumor agent.
      PROCESS: The 4-carbamoylimidazolium-5-olate of formula II or its trimethylsilyl derivative is made to react with the glycose derivative of formula R'-Z (R' is β-D-glucopyranosyl, β-D-mannopyranosyl, etc.; Z is halogen, lower alkoxy, etc.) in the presence of stannic chloride and a condensation agent to obtain the compound of formula III, which is if necessary deacylated under basic condition.
      COPYRIGHT: (C)1984,JPO&Japio
    • 新物质:式I化合物(R为β-D-吡喃葡萄糖基,β-D-吡喃半乳糖基,2-乙酰氨基-2-脱氧-β-D-吡喃葡萄糖基,α-L-鼠李糖吡喃糖基,β-D-吡喃半乳糖基,β D-阿拉伯呋喃糖基等)。 实施例:4-氨甲酰基-1-(2,3,4,6-四-O-乙酰基-β-D-吡喃半乳糖基) - 咪唑鎓-5-醇酸酯(I:R = 2,3,4,6-四 - -O-乙酰基-β-D-吡喃半乳糖基)。 用途:免疫抑制剂和抗肿瘤剂。 方法:使式II的4-氨基甲酰基咪唑鎓-5-醇酸酯或其三甲基甲硅烷基衍生物与式R'-Z(R'是β-D-吡喃葡萄糖基,β-D-吡喃甘露糖基等)的糖苷衍生物反应。 Z是卤素,低级烷氧基等)在氯化锡和缩合剂的存在下,得到式III化合物,如果需要,在碱性条件下脱酰基。
    • 2. 发明专利
    • Optically active imidazolylpropanediol derivative and its preparation
    • 光学有效的咪唑并吡喃衍生物及其制备
    • JPS58203974A
    • 1983-11-28
    • JP5332783
    • 1983-03-28
    • Sumitomo Chem Co Ltd
    • SAJI KITAROUSATOU RENZOUAONO SHIYUNJIICHINOSE KATSUAKIOKUDA TAKAOATAMI TOSHIO
    • C07D233/60A61K31/415A61P31/04A61P31/10
    • NEW MATERIAL:(R)-2-(2,4-Dichlorophenyl)-1-(imidazol-1-yl)-2,3-propanediol of formula I .
      USE: A synthetic intermediate of optically active imidazolylalkylthiopropanol derivative having strong mycostatic activity.
      PROCESS: The optically active diol derivative of formula I can be prepared e.g. by (1) reacting the racemic imidazolyldiol derivative of formula II with an optically active carboxylic acid or its reactive derivative, preferably the optically active carboxylic acid of formula III to obtain the 1:1 mixture of two kinds of diastereomer esters, (2) separating the objective ester from the diastereomer mixture by chromatography, fractional recrystallization, etc., and (3) hydrolyzing the resultant ester.
      COPYRIGHT: (C)1983,JPO&Japio
    • 新材料:式I的(R)-2-(2,4-二氯苯基)-1-(咪唑-1-基)-2,3-丙二醇。 用途:具有很强的静电活性的光学活性咪唑基烷基硫代丙醇衍生物的合成中间体。 方法:式I的光学活性二醇衍生物可以例如制备。 通过(1)使式II的外消旋咪唑烷二醇衍生物与光学活性羧酸或其反应性衍生物,优选式III的光学活性羧酸反应,得到两种非对映体酯的1:1混合物,(2)分离 通过色谱法,分级重结晶等来自非对映异构体混合物的目标酯,和(3)水解所得酯。
    • 4. 发明专利
    • Novel 1-substituted imidazole-4-carboxamide
    • 新一代取代的咪唑-4-羧酰胺
    • JPS5925390A
    • 1984-02-09
    • JP13545582
    • 1982-08-02
    • Sumitomo Chem Co Ltd
    • TARUMI YUUZOUATAMI TOSHIOYOSHIDA NOBORUFUKUI MASARU
    • C07D409/04A61K31/415A61P31/12A61P35/00A61P37/06C07D405/04
    • NEW MATERIAL:A Compound of formula I (A is O, S, sulfinyl or sulfonyl; B is lower alkylene; R is H, hydroxymethyl, acyloxymethyl, alkoxycarbonyl or carboxyl).
      EXAMPLE: 4-Carbamoyl-1-tetrahydrofurylimidazolium-5-oleate.
      USE: Useful as an antitumor agent having powerful inhibitory action on the multiplication of tumorous cells with very low toxicity, and orally administrable.
      PROCESS: 4-Carbamoylimidazolium-5-oleate (or a reactive derivative thereof) is reacted with a compound of formula II (R' is H, acyloxymethyl or alkoxycarbonyl; Y is halogen, lower alkoxyl, trimethylsilyloxy or aroyloxy, etc.) if necessary in the presence of a condensing agent, e.g. trimethylsilyl trifluoromethanesulfonate, and if necessary further hydrolyzed.
      COPYRIGHT: (C)1984,JPO&Japio
    • 新材料:式I化合物(A为O,S,亚磺酰基或磺酰基; B为低级亚烷基; R为H,羟甲基,酰氧基甲基,烷氧基羰基或羧基)。 实施例:4-氨基甲酰基-1- tetrahydrofurylimidazolium-5油酸酯。 用途:作为具有非常低毒性的肿瘤细胞增殖具有强大抑制作用的抗肿瘤剂,可口服给药。 方法:如果需要,将4-氨基甲酰基咪唑鎓-5-油酸酯(或其活性衍生物)与式II化合物(R'是H,酰氧基甲基或烷氧基羰基; Y是卤素,低级烷氧基,三甲基甲硅烷氧基或芳酰氧基等) 在冷凝剂的存在下,例如 三氟甲磺酸三甲基甲硅烷基酯,如果需要,进一步水解。
    • 5. 发明专利
    • Novel alkylimidazole derivative
    • 新的阿基咪唑衍生物
    • JPS5748971A
    • 1982-03-20
    • JP12497480
    • 1980-09-08
    • Sumitomo Chem Co Ltd
    • ATAMI TOSHIOTARUMI YUUZOU
    • C07D233/90A61K31/415A61P29/00
    • NEW MATERIAL:An imidazole derivative shown by the formula I(R
      1 is lower alkyl or aralkyl; R
      2 and R
      3 are H, lower alkyl or aralkyl) and its salt.
      EXAMPLE: 5-Carbamoyl-1-methylimidazolium-4-oleate.
      USE: An anti-inflammatory agent. Having improved inhibiting actions on calabar swelling.
      PROCESS: An amine shown by the formula R
      1 -NH
      2 is reacted with α-bromomalonamide shown by the formula II to give an α-aminomalonamide derivative shown by the formula III, which is reacted with an ortho-formate in the presence or absence of a catalyst to give a compound shown by the formula IV. If, necessary, this compound is reacted with an alkylating agent to give a compound shown by the formula V(R'
      2 is lower alkyl or aralkyl), and optionally treated with an alkali to give a rearranged reaction product shown by the formula VI.
      COPYRIGHT: (C)1982,JPO&Japio
    • 新材料:由式I表示的咪唑衍生物(R1为低级烷基或芳烷基; R2和R3为H,低级烷基或芳烷基)及其盐。 实施例:5-氨基甲酰基-1-甲基咪唑-4-油酸酯。 用途:抗炎剂。 改善对颅骨肿胀的抑制作用。 方法:式R 1 -NH 2所示的胺与由式II表示的α-溴代马来酰胺反应,得到式III表示的α-氨基马来酰亚胺衍生物,其与原甲酸酯反应,在存在或不存在下 催化剂,得到式IV所示的化合物。 如果必要的话,该化合物与烷基化剂反应,得到式V所示的化合物(R'2是低级烷基或芳烷基),任选地用碱处理,得到式VI所示重排的反应产物。
    • 7. 发明专利
    • Novel imidazole nucleoside and its preparation
    • 新型咪唑烷核苷及其制备方法
    • JPS5936695A
    • 1984-02-28
    • JP14531482
    • 1982-08-20
    • Sumitomo Chem Co Ltd
    • TARUMI YUUZOUATAMI TOSHIOYOSHIDA NOBORU
    • C07H19/052A61K31/70A61K31/7042A61K31/7052A61K31/7056A61P35/00A61P37/06C07H19/04
    • NEW MATERIAL:An imidazole nucleoside shown by the formula I [R
      1 is group shown by the formula II (one of R
      3 and R
      4 is OH, acyloxy, or acetamide, and the other is H; one of R
      5 and R
      6 , and R
      7 and R
      8 is OH, acyloxy, and the other is H; one of R
      9 and R
      10 is H, CH
      3 , CH
      2 OH, acyloxymethyl, and the other is H), the formula III (one of R
      11 and R
      12 , and R
      13 and R
      14 is OH, acyloxy, and the other is H; one of R
      15 and R
      16 is CH
      2 OH' or acyloxymethyl, and the other is H); R
      2 is H, or R
      1 ].
      EXAMPLE: 5-Carbamoyl-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl) imidazolium-4-olate.
      USE: A water-soluble carcinostatic agent, immunosuppressive agent.
      PROCESS: For example, a compound shown by the formula IV is reacted with a saccharide derivative shown by the formula V (R'
      3 WR'
      8 are groups R
      3 WR
      8 other than OH; R'
      9 WR'
      10 are groups R
      9 and R
      10 other than CH
      2 OH; R
      17 is halogen, etc.) in the presence of a condensation agent, and if necessary, deacylated, to give a compound shown by the formula I (with the proviso that R
      1 = group shown by the formula II).
      COPYRIGHT: (C)1984,JPO&Japio
    • 新材料:由式I表示的咪唑核苷[R1为式Ⅱ所示的基团(R3和R4之一为OH,酰氧基或乙酰胺,另一个为H; R5和R6之一,R7和R8 是OH,酰氧基,另一个是H; R 9和R 10之一是H,CH 3,CH 2 OH,酰氧基甲基,另一个是H),式III(R 11和R 12之一,R 13和R 14是OH,酰氧基 ,另一个为H; R 15和R 16中的一个为CH 2 OH或酰氧基甲基,另一个为H); R2是H或R1]。 实施例:5-氨基甲酰基-1-(2,3,5-三-O-乙酰基-β-D-呋喃核糖基)咪唑鎓-4-醇酸酯。 用途:水溶性制剂,免疫抑制剂。 方法:例如,式IV所示的化合物与式V所示的糖衍生物(R'3-R'8是不同于OH的R3-R8基团; R'9-R'10是基团R9 和R 10,除了CH 2 OH; R 17是卤素等),并且如果需要,进行脱酰基化,得到式I所示的化合物(条件是R1 =式II所示的基团) 。
    • 8. 发明专利
    • Optically active imidazolylmethyloxirane derivative and its preparation
    • 光学活性的咪唑啉衍生物衍生物及其制备
    • JPS58203988A
    • 1983-11-28
    • JP5332683
    • 1983-03-28
    • Sumitomo Chem Co Ltd
    • SAJI KITAROUSATOU RENZOUAONO SHIYUNJIICHINOSE KATSUAKIOKUDA TAKAOATAMI TOSHIO
    • C07C57/58C07B31/00C07B57/00C07C51/00C07C67/00C07D405/06
    • NEW MATERIAL:(R)-2-(2,4-Dichlorophenyl)-2-(imidazol-1-yl)methyloxirane of formula I .
      USE: A synthetic intermediate of optically active imidazolylalkylthiopropanol derivative having strong antifungal activity.
      PROCESS: The racemic isomer of the imidazolyldiol derivative of formula II is made to react with an optically active carboxylic acid (or its reactive derivative) (preferably the compound of formula III) to obtain two kinds of diastereomer esters, from which the objective ester is separated. The separated ester is hydrolyzed under alkaline condition, and the resultant optically active imidazolyldiol derivative of formula IV is methylated with methanesulfonyl chloride, and without isolating from the reaction system, treated with an alkali to obtain the objective compound of formula I .
      COPYRIGHT: (C)1983,JPO&Japio
    • 新材料:式I的(R)-2-(2,4-二氯苯基)-2-(咪唑-1-基)甲基环氧乙烷。 用途:具有强抗真菌活性的光学活性咪唑基烷基硫代丙醇衍生物的合成中间体。 方法:使式II的咪唑烷二醇衍生物的外消旋异构体与光学活性羧酸(或其反应性衍生物)(优选式III化合物)反应,得到两种非对映异构体酯,其中目标酯为 分开 将分离的酯在碱性条件下水解,将得到的式Ⅳ的旋光性咪唑烷二醇衍生物用甲磺酰氯甲基化,不用从反应体系中分离,用​​碱处理,得到目的化合物Ⅰ。